Bivalirudin
Not Tagged
[]
late breaking trials: among patients with stemi undergoing primary pci with radial artery access, bivalirudin reduced 30-day composite of all-cause mortality or major bleeding compared to heparin monotherapy, bright-4 presented by #aha22 
Chief #Wellbeing Liaison, Dir CVD #Prevention & #WomenHeart @OSUWexMed @OhioStateMed | Past-Pres @OhioACC @AmHeartOhio of Cbus | @ELAMProgram | Tweets ? advice